Wikisage, the free encyclopedia of the second generation, is digital heritage
Nephrotic syndrome: Difference between revisions
Jump to navigation
Jump to search
(→Links: 1993) |
(→Links: 2) |
||
| Line 4: | Line 4: | ||
==Links== | ==Links== | ||
[http://www.nature.com/ki/journal/v43/n6/pdf/ki1993194a.pdf A randomized trial of cyclosporine in steroid-resitant idiopathic nephrotic syndrome] | *[http://www.nature.com/ki/journal/v43/n6/pdf/ki1993194a.pdf A randomized trial of cyclosporine in steroid-resitant idiopathic nephrotic syndrome] | ||
*[http://www.nature.com/ki/journal/v44/n3/pdf/ki1993292a.pdf The increased risk of coronary heart disease asociated with nephrotic syndrome] | |||
[[nl:Nefrotisch syndroom]] | [[nl:Nefrotisch syndroom]] | ||
Revision as of 23:35, 23 July 2015
Disease classification WHO
N04 Nephrotic syndrome
Nephrotic syndrome is a nonspecific kidney disorder characterized by a number of signs of disease: proteinuria, hypoalbuminemia and edema. It is characterized by an increase in permeability of the capillary walls of the glomerulus leading to the presence of high levels of protein passing from the blood into the urine (proteinuria at least 3.5 grams per day per 1.73m2 body surface area); (> 40 mg per square meter body surface area per hour ) low levels of protein in the blood (hypoproteinemia or hypoalbuminemia), ascites and in some cases, edema; high cholesterol (hyperlipidaemia or hyperlipemia) and a predisposition for coagulation[1]
Links
- A randomized trial of cyclosporine in steroid-resitant idiopathic nephrotic syndrome
- The increased risk of coronary heart disease asociated with nephrotic syndrome